Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cetrimide adverse reaction |
Causative agent |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Allergy to cetrimide (finding) |
Causative agent |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
Product containing precisely cetrimide 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
Product containing cetrimide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide 10 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
cetrimid 20 % stærk opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
cetrimid 40 % stærk opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
Cetrimide cream BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
Cetrimide 0.5% cream BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
Product containing precisely benzalkonium chloride 100 microgram/1 gram and cetrimide 2 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
chlorhexidingluconat + cetrimid 0,05 %/0,5 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
chlorhexidingluconat + cetrimid 1,5 %/15 % væske til topikal anvendelse, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
chlorhexidingluconat + cetrimid 0,015 %/0,15 % topikal væske, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
Benzalkonium chloride+cetrimide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
Product containing cetrimide and chlorhexidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Product containing benzalkonium and cetrimide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Product containing cetrimide and dimeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Product containing cetrimide and witch hazel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Allergy to cetrimide (finding) |
Causative agent |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide 200 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
Cetrimide 400 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
|
Cetrimide 10 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide 10 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benzalkonium chloride 100 microgram/1 gram and cetrimide 2 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benzalkonium chloride 100 microgram/1 gram and cetrimide 2 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cetrimide 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cetrimide 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Benzalkonium- and cetrimide-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Cetrimide-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide- and chlorhexidine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Cetrimide- and dimeticone 1000-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide- and dimeticone 1000-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Benzalkonium and cetrimide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Cetrimide and chlorhexidine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Product containing only cetrimide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Product containing only cetrimide and dimeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Product containing only cetrimide and dimeticone 1000 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide and witch hazel only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Benzalkonium and cetrimide only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Cetrimide and chlorhexidine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Cetrimide and dimeticone 1000 only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Product containing only cetrimide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide 200 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide 200 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide 400 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide 400 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
chlorhexidingluconat + cetrimid 0,05 %/0,5 % opløsning |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
chlorhexidingluconat + cetrimid 0,05 %/0,5 % opløsning |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Cetrimide 5 mg/mL and chlorhexidine gluconate 500 microgram/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Cetrimide 5 mg/mL and chlorhexidine gluconate 500 microgram/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
1 |
Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |
Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetrimide (substance) |
Inferred relationship |
Some |
2 |